跳至主要内容
临床试验/CTRI/2022/02/040297
CTRI/2022/02/040297已完成2 期

Preclinical and clinical evaluation of the effect on oral administration of PARUMA NOI NIVARANA MAATHIRAI & NEERMULLI OORAL KUDINEER along with external therapy PODI THIMIRTHAL in the management of BAALAR ATHITHOOLA ROGAM.

Dr J Mangalavalli1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年2月18日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
1.To reduce the excess weight

研究概览

简要总结

The study is a single arm clinical trial focussing on preclinical and clinical evaluation of the effect on oral adminiostration of PARUMA NOI NIVARANA MAATHIRAI & NEERMULLI OORAL KUDINEER along with  external therapy PODI THIMIRTHAL in the management of BAALAR ATHITHOOLA ROGAM.

If any ADR is encountered , it will be reported to Pharmacovigilance department , SCRU Palayamkottai.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
5.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • 1.Inappropriate weight for height 2.Raised BMI 3.Abdominal adiposity 4.Increased skin fold thickness All of these associated with any one of the following : a.Shortness of breath b.Dark and thickened skin especially in the skin folds and creases c.Joint pain d.Trouble sleeping 5.Willing for regular follow-up in OPD 6.Willing to put admission in IPD.

排除标准

  • 1.Children above 12 years 2.Children below 5 years 3.Cases due to endocrine reasons 4.Hypothalamic obesity 5.Genectic syndromes 6.Monogenic disorders 7.Under the use of antiepileptic drugs,corticosteroids,antipsychotics,antidepressants and oestrogen.

结局指标

主要结局

1.To reduce the excess weight

时间窗: 40 days

2.To maintain weight within normal limits.

时间窗: 40 days

次要结局

未报告次要终点

研究者

发起方
Dr J Mangalavalli
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验